The FDA classified the recall as a Class I, the most serious type, according to a Feb. 23 news release.
A total of 35 complaints have been received since December 2021. Of the 35 complaints, there have been 14 reported injuries, and nine complaints involved use of a stent to manage the separated tip. No deaths have been reported at this time, according to the FDA.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
